We're sorry but the Program doesn't work properly without JavaScript enabled. Please enable it to continue.
Horizontal
Vertical
List
Program
Chairs & Speakers
Favourites
Download Program
Help
Event Times (GMT+1)
Local Times (GMT+2)
Login
Session Groups
Session Types
Networking
Data Blitz Session
Spotlight Session
Symposium
Meet the Experts / Campfire Session
Plenary
Break
Session
Industry
Posters
Featured Communication
Rooms
Back
Derek Chalmers
Oban BioPharma, Stamford, CT 06901, United States
In presentations
Sunday, June 28, 01:20 PM – 01:20 PM
Discovery and Preclinical Development of a Novel Muscarinic M4 Ago-PAM for the Treatment of Schizophrenia
Speaker: Derek Chalmers (Oban BioPharma, CEO, Stamford, CT 06901, United States)
